Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Robesti

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Clinical Genitourinary Cancer|October 4, 2025
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome InterpretationDaniele Robesti, Filippo Micheli, Shesh N Rai, et al.
European Urology Oncology|August 15, 2019
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate CancerAlberto Martini, Giorgio Gandaglia, Nicola Fossati, et al.
European Urology Oncology|April 2, 2023
Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution SeriesRiccardo Leni, Giorgio Gandaglia, Armando Stabile, et al.
European Urology|November 10, 2018
Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term OutcomesGiorgio Gandaglia, Matteo Soligo, Antonino Battaglia, et al.
Cancer Cell|June 13, 2025
Senescence in cancerManuel Colucci, Miles Sarill, Martino Maddalena, et al.
The Prostate|December 27, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancerFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
World Journal of Urology|June 16, 2023
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancerAntony Pellegrino, Giorgio Gandaglia, Mario de Angelis, et al.
Journal of Clinical Medicine|February 25, 2023
Understanding the Role of Ureteral Access Sheath in Preventing Post-Operative Infectious Complications in Stone Patients Treated with Ureteroscopy and Ho:YAG Laser Lithotripsy: Results from a Tertiary Care Referral CenterLuca Villa, Pietro Dioni, Luigi Candela, et al.
Urologic Oncology|December 17, 2024
Perioperative outcomes, environmental impact and economic implications of pelvic drain discontinuation in prostate cancer patients undergoing robot-assisted radical prostatectomySimone Scuderi, Pietro Scilipoti, Luigi Nocera, et al.
BJU International|June 1, 2026
Complications following repeated ureteroscopy for UTUC: The price to pay for nephron-sparing surgeryPietro Scilipoti, Angelo Occhi, Daniele Robesti, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Clinical Genitourinary Cancer|October 4, 2025
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome InterpretationDaniele Robesti, Filippo Micheli, Shesh N Rai, et al.
European Urology Oncology|August 15, 2019
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate CancerAlberto Martini, Giorgio Gandaglia, Nicola Fossati, et al.
European Urology Oncology|April 2, 2023
Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution SeriesRiccardo Leni, Giorgio Gandaglia, Armando Stabile, et al.
European Urology|November 10, 2018
Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term OutcomesGiorgio Gandaglia, Matteo Soligo, Antonino Battaglia, et al.
Cancer Cell|June 13, 2025
Senescence in cancerManuel Colucci, Miles Sarill, Martino Maddalena, et al.
The Prostate|December 27, 2023
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancerFrancesco Pellegrino, Armando Stabile, Gabriele Sorce, et al.
World Journal of Urology|June 16, 2023
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancerAntony Pellegrino, Giorgio Gandaglia, Mario de Angelis, et al.
Journal of Clinical Medicine|February 25, 2023
Understanding the Role of Ureteral Access Sheath in Preventing Post-Operative Infectious Complications in Stone Patients Treated with Ureteroscopy and Ho:YAG Laser Lithotripsy: Results from a Tertiary Care Referral CenterLuca Villa, Pietro Dioni, Luigi Candela, et al.
Urologic Oncology|December 17, 2024
Perioperative outcomes, environmental impact and economic implications of pelvic drain discontinuation in prostate cancer patients undergoing robot-assisted radical prostatectomySimone Scuderi, Pietro Scilipoti, Luigi Nocera, et al.
BJU International|June 1, 2026
Complications following repeated ureteroscopy for UTUC: The price to pay for nephron-sparing surgeryPietro Scilipoti, Angelo Occhi, Daniele Robesti, et al.
Pageof 6